IQVIA Holdings Inc. (0JDM.L)

USD 153.88

(1.18%)

Total Debt Summary of IQVIA Holdings Inc.

  • IQVIA Holdings Inc.'s latest annual total debt in 2023 was 14.23 Billion USD , up 9.38% from previous year.
  • IQVIA Holdings Inc.'s latest quarterly total debt in 2024 Q2 was 13.45 Billion USD , down -2.11% from previous quarter.
  • IQVIA Holdings Inc. reported annual total debt of 13.01 Billion USD in 2022, up 4.61% from previous year.
  • IQVIA Holdings Inc. reported annual total debt of 12.43 Billion USD in 2021, down -3.61% from previous year.
  • IQVIA Holdings Inc. reported quarterly total debt of 13.51 Billion USD for 2024 Q3, up 1.86% from previous quarter.
  • IQVIA Holdings Inc. reported quarterly total debt of 13.45 Billion USD for 2024 Q2, down -2.11% from previous quarter.

Annual Total Debt Chart of IQVIA Holdings Inc. (2023 - 2011)

Historical Annual Total Debt of IQVIA Holdings Inc. (2023 - 2011)

Year Total Debt Total Debt Growth
2023 14.23 Billion USD 9.38%
2022 13.01 Billion USD 4.61%
2021 12.43 Billion USD -3.61%
2020 12.9 Billion USD 7.17%
2019 12.04 Billion USD 9.39%
2018 11 Billion USD 7.65%
2017 10.22 Billion USD 42.01%
2016 7.2 Billion USD 191.76%
2015 2.46 Billion USD 7.61%
2014 2.29 Billion USD 12.09%
2013 2.04 Billion USD -15.52%
2012 2.42 Billion USD 22.83%
2011 1.97 Billion USD 0.0%

Peer Total Debt Comparison of IQVIA Holdings Inc.

Name Total Debt Total Debt Difference
uniQure N.V. 138.4 Million USD -10181.846%
Abeona Therapeutics Inc. 4.4 Million USD -323184.871%
Aclaris Therapeutics, Inc. 3.07 Million USD -462847.3%
Agios Pharmaceuticals, Inc. 56.98 Million USD -24871.924%
Atara Biotherapeutics, Inc. 57.87 Million USD -24490.476%
Cara Therapeutics, Inc. 43.16 Million USD -32867.313%
Imunon, Inc. 1.13 Million USD -1249007.999%
Dynavax Technologies Corporation 256.91 Million USD -5439.208%
Editas Medicine, Inc. 36.53 Million USD -38850.624%
FibroGen, Inc. 170.45 Million USD -8248.831%
Iovance Biotherapeutics, Inc. 1 Million USD -1423000.0%
Kala Pharmaceuticals, Inc. 36.32 Million USD -39079.033%
Neurocrine Biosciences, Inc. 428.4 Million USD -3221.895%
Sarepta Therapeutics, Inc. 1.39 Billion USD -918.823%
Supernus Pharmaceuticals, Inc. 41.52 Million USD -34169.271%
Verastem, Inc. 41.55 Million USD -34144.532%
Zoetis Inc. 6.8 Billion USD -109.187%
Vertex Pharmaceuticals Incorporated 808.4 Million USD -1660.391%
Sangamo Therapeutics, Inc. 38.1 Million USD -37247.785%
Homology Medicines, Inc. 44.05 Million USD -32203.537%
Nektar Therapeutics 230.4 Million USD -6076.622%
Viking Therapeutics, Inc. 1.26 Million USD -1129344.444%
Unity Biotechnology, Inc. 26.99 Million USD -52626.936%
Perrigo Company plc 4.07 Billion USD -249.364%
Esperion Therapeutics, Inc. 540.94 Million USD -2530.757%
Walgreens Boots Alliance, Inc. 9.55 Billion USD -48.953%
Illumina, Inc. 2.26 Billion USD -529.134%
Thermo Fisher Scientific Inc. 34.91 Billion USD 59.243%
Heron Therapeutics, Inc. 173.75 Million USD -8090.362%
Waters Corporation 2.35 Billion USD -504.157%
Biogen Inc. 7.33 Billion USD -93.93%
Evolus, Inc. 126.54 Million USD -11145.713%
Adicet Bio, Inc. 17.7 Million USD -80287.505%
bluebird bio, Inc. 330.32 Million USD -4208.168%
Geron Corporation 85.89 Million USD -16467.131%
Alnylam Pharmaceuticals, Inc. 2.39 Billion USD -493.449%
Amicus Therapeutics, Inc. 445.05 Million USD -3097.554%
Myriad Genetics, Inc. 145 Million USD -9714.483%
Intellia Therapeutics, Inc. 115.34 Million USD -12237.662%
Mettler-Toledo International Inc. 2.16 Billion USD -556.481%
Corbus Pharmaceuticals Holdings, Inc. 20.88 Million USD -68042.319%
BioMarin Pharmaceutical Inc. 1.13 Billion USD -1155.077%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD -426.509%
Agilent Technologies, Inc. 2.73 Billion USD -420.329%
OPKO Health, Inc. 326.56 Million USD -4257.798%
Exelixis, Inc. 189.94 Million USD -7392.208%
Corcept Therapeutics Incorporated 151 Thousand USD -9424403.311%
Anavex Life Sciences Corp. - USD -Infinity%
Axsome Therapeutics, Inc. 186.37 Million USD -7535.804%
Ionis Pharmaceuticals, Inc. 1.45 Billion USD -879.059%
Halozyme Therapeutics, Inc. 1.49 Billion USD -849.209%
Blueprint Medicines Corporation 774.12 Million USD -1738.341%
Insmed Incorporated 1.2 Billion USD -1081.983%
TG Therapeutics, Inc. 110.79 Million USD -12744.442%
Incyte Corporation 38.28 Million USD -37069.274%
Emergent BioSolutions Inc. 877.5 Million USD -1521.766%